Goethe Universität Logo DFG Logo LiFF Logo Max Planck Institut Logo

SFB 1039

Krankheitsrelevante Signaltransduktion
durch Fettsäurederivate und Sphingolipide

Archiv Seminarreihe



Vortragsreihe "Seminars in Lipid Signalling"

SFB 1039 Krankheitsrelevante Signaltransduktion durch Fettsäurederivate und Sphingolipide

 


Datum Sprecher Vortragstitel
04.02.2014 Prof. Dr. Dagmar Kratky
Center of Molecular Medicine
Medical University of Graz
Cellular and systemic adaptations of defective lipolysis: lessons from knockout mouse models
18.03.2014 Prof. Dr. Isabelle Maridonneau Parini
Institut de Pharamacologie et de Biologie Structurale CNRS UMR5089 Toulouse, France
Molecular and cellular mechanisms of macrophage migration in 3-dimensional environments and HIV-1 hijacking
22.04.2014 Prof. Dr. Georg Reiser
Institut für Neurobiochemie Medizinische Fakultät
der Otto-von-Guericke Universität Magdeburg
Lipids in Neurodegeneration and protection: The lipid sensors PPAR (peroxisome proliferator-activated receptors) and the iPLA2
06.05.2014 Prof. Dr. Olivier Cuvillier, PhD
IPBS, Institute of Pharmacology and Structural Biology
Department of Cancer Biology. Toulouse, France
Sphingosine 1-phosphate in the regulation of hypoxia in cancer
03.06.2014 Prof. Dr. Sibylle Schneider-Schaulies
Julius-Maximilians-Universität Würzburg
Institut für Virologie und Immunbiologie
The role of sphingomyelinase activation in Measles Virus induced T cell paralysis: modulation of activation thresholds?
11.06.2014 William B. Campbell, Ph.D.
Professor and Chairman
Department of Pharmacology and Toxicology Medical College of Wisconsin, Milwaukee, USA
Inducible Endothelium-derived Hyperpolarizing factor: Adapting vasodilation to physiological changes .
01.07.2014 Prof. Dr. Rolf Müller
Institute of Molecular Biology and Tumor Research (IMT)
Philipps University Marburg
Regulation of tumorigenesis-associated functions by the nuclear receptor PPARβ/δ
05.08.2014 Prof. Dr. Stefan Uhlig
Rheinisch-Westfälische Technische Hochschule Aachen Universitätsklinikum Aachen Institut für Pharmakologie und Toxikologie
The multiple roles of the acid sphingomyelinase in sepsis and lung injury
02.09.2014 Prof. Dr. Bodo Levkau
Institute of Pathophysiology, Center of Internal Medicine University of Essen Medical School
Sphingosine-1-phosphate in Atherosclerosis injury
07.10.2014 Assia Shisheva, Ph.D. Professor of Physiology
Wayne State University School of Medicine Detroit, USA
540 E. Canfield Av., Detroit
PtdIns3, 5P2 and PtdIns5P: Enzymology, Signalling and Disease
04.11.2014 Prof. Dr. Tobias Hartmann
Professor für Experimentelle Neurologie an der Universität des Saarlandes
Crossing the line - lipids in Alzheimer’s disease prevention and progression
02.12.2014 Prof. Dr. Bernhard Hermann Rauch
Universitätsmedizin Greifswald Institut für Pharmakologie Abteilung Allgemeine Pharmakologie
Modulation of the sphingosine-1-phosphate pathway by coagulation factors
12.02.2015
Haus 22, Hörsaal 2
Prof. Dr. Dr. Detlef Schuppan
Professor für Molekulare und Translationale Medizin
(Fibrose- und Zöliakieforschung) an der Johannes Gutenberg-Universität Mainz. Professor of Medicine and Senior Visiting Scientist Harvard Medical School. Direktor Zöliakie- und Dünndarmzentrum
Antifibrotic therapies for liver fibrosis: from bench to bedside
03.03.2015
Haus 74, Seminarraum 4.107
Prof. Dr. Hermann-Josef Gröne
Zelluläre und Molekulare Pathologie Deutsches Krebsforschungszentrum Heidelberg
Interplay of Transcription Factors and Sphingolipids
14.04.2015
Haus 74, Seminarraum 4.107
PD Dr. med. Andreas Vlachos
Institut für klinische Neuroanatomie
Goethe-Universität Frankfurt
Dr. Senckenbergische Anatomie
Neuroscience Center Frankfurt
Role of Sphingosine-1-phosphate receptor signaling in denervation-induced dendritic plasticity
12.05.2015
Haus 74, Seminarraum 4.107
Professor Dr. Erich Gulbins
Universitätsklinikum Essen
Institut für Molekularbiologie (Tumorforschung)
Sphingolipids in Cystic Fibrosis
11.06.2015
Haus 22, Hörsaal 2
Prof. Dr. Tobias Hartmann
Deutsches Institut für Demenzprävention (DIDP)
Experimental Neurology, Medical Campus of the Saarland University
Crossing the line - lipids in Alzheimer’s disease prevention and progression
23.07.2015
18 Uhr,
Haus 22
Prof. Dr. rer.nat.Burkhard Kleuser
Director of the Institute of Nutritional Science,
Faculty of Mathematics and Natural Science,
Universität Potsdam (Germany)
Role of Sphingosine 1-phosphate in Insulin-sensitive tissues
29.09.2015
Haus 74, Seminarraum 4.107
Nader G Abraham, PhD., Dr. H.C., FAHA
Professor of Medicine and Pharmacology
New York Medical College
EETs and 20-HETE are intracellular lipid-mediators that differentially regulate obesity and vascular diseases
08.10.2015
Haus 22, Hörsaal 2
Prof. Dr. Enrico Rovati
Chief, Laboratory of Molecular Pharmacology Department of Pharmacological and Biomolecular Sciences,
University of Milan
Time for a new twist in NSAID pharmacology: the thromboxane prostanoid receptor at stage
13.10.2015
Haus 74, Seminarraum 4.107
Prof. Dr. David H. Thompson
Department of Chemistry
Purdue University
Interfacial Design in Drug Delivery and CryoEM – Plasmalogen Reaction Dynamics and Novel Tools for Single Particle Reconstruction Analysis
24.11.2015
Haus 74, Seminarraum 4.107
Prof. Dr. Charles A. Dinarello
Division of Infectious Diseases
University of Colorado
IL-37, the IL-1 Family Member that we never expected
01.12.2015
18:00 Uhr
Haus 22, PE-Hörsaal
Prof. Timothy T. Hla
Center for Vascular Biology
Weill Cornell Medical College, Cornell University, New York, USA
Adventures with Bioactive Lipids
01.12.2015
Haus 74, Seminarraum 4.107
Professor Dr. Johannes Kornhuber
Universitätsklinikum Erlangen
AöR Psychiatrische und Psychotherapeutische Klinik
Sphingolipids in psychiatric disorders
08.12.2015
Haus 74, Seminarraum 4.107
Dr. rer. nat. Ina Maria Schießl
Universität Regensburg
Effects of Angiotensin II on the glomerular filtration barrier
09.12.2015
Haus 74, Seminarraum 4.107
Dr. Alexander Carpinteiro
Universitätsklinikum Essen
The role of acid sphingomyelinase in tumor metastasis
10.12.2015
Haus 22, Hörsaal 2
Prof. Dr. Rudolf Zechner
Karl-Franzens-Universität Graz
Institut für Molekulare Biowissenschaften
Lipolysis - a potential drug target to for obesity and insulin resistance
25.02.2016
18 Uhr
Eric Camerer, PhD Assistant Professor
Cardiovascular Research Center Hôpital europén Georges-Pompidou
Paris, Frankreich
Roles of circulating sources of sphingosine-1-phosphate in the regulation of vascular integrity and tone
15.03.2016
Professor Mark Exley
University of Manchester
Institute for Pharmaceutical Chemistry
Understanding and Exploiting lipid-reactive NKT cell populations in health and disease
22.03.2016
Professor Dr. Stefan Knapp
Goethe-University Frankfurt
Institute for Pharmaceutical Chemistry
Application of chemical probes as tools for target validation
28.04.2016
18 Uhr
H27
(Hörsaal der Anatomie / Ernst und Berta Scharrer-Hörsaal)
Professor Mario Romano
University "G. D'Annunzio"
Chieti, Italy
Pro-resolution lipid mediators and receptors: Novel signaling pathways and regulatory mechanisms
24.05.2016
Per Haberkant, PhD
Leiden University | Leiden Institute of Chemistry (LIC)
Department Biochemistry Niederlande
A Quantitative Map of Cellular Sphingolipid-Protein Complexes Revealed by Large-Scale Systematic Profiling
31.05.2016
Professor Joan Massagué
Direktor, Sloan Kettering Cancer Center
New York
Contextual determinants of TGFß signalling
07.06.2016
Professor Dr. med. Hermann-Joseph Pavenstädt
Universitätsklinikum Münster
Role of the WWC-Hippo signaling in the kidney
21.06.2016
Professor Dr. Johannes Kornhuber Universitätsklinikum Erlangen
AöR Psychiatrische und Psychotherapeutische Klinik
Sphingolipids in psychiatric disorders.
12.07.2016
WIRD VERSCHOBEN
Carsten Schultz
Group Leader and Senior Scientist
Cell Biology & Biophysics Unit
EMBL Heidelberg
Chemical biology tools to study lipid signaling
12.10.2016
Professor Per-Johan Jakobsson
Uppsala University
Karolinska Institutet Stockholm
Sweden
Recent findings on the impact of mPGES-1 inhibition in cancer, inflammation and the cardiovascular system
25.10.2016
Sara Gonçalves, MD
Institut Imagine Inserm U1163, Paris
SGPL1 mutations as a novel cause of steroid resistant nephrotic syndrome, adrenal insufficiency and ichtyosis in humans
15.11.2016
Professor Christer Betsholtz
Uppsala University
Karolinska Institutet Stockholm
Sweden
Microvascular pericytes and their role in the blood-brain barrier